Search
                    Ohio Paid Clinical Trials
A listing of 3204  clinical trials  in Ohio  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            2437 - 2448 of 3204
        
                Ohio is currently home to 3204 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Cincinnati, Columbus, Cleveland and Dayton. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
                                
            
            
        Recruiting
                            
            
                The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.             
        
        
    Gender:
                ALL
            Ages:
                Between 3 days and 2 years
            Trial Updated:
                02/07/2025
            
            Locations: Rainbow Babies and Children's Hospital, Cleveland, Ohio         
        
        
            Conditions: Respiratory Syncytial Virus Infections
        
            
        
    
                
                                    Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
                                
            
            
        Recruiting
                            
            
                The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/06/2025
            
            Locations: Lower Extremity Institute of Research and Therapy, Boardman, Ohio         
        
        
            Conditions: Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers
        
            
        
    
                
                                    Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
                                
            
            
        Recruiting
                            
            
                This clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections that last only a few months, but sometimes can last longer. It is known to cause a variety of cancers including cancer of the cervix. Even though there are ways to detect cervical cancer early, many individuals do not un...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                25 years and above
            Trial Updated:
                02/06/2025
            
            Locations: University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio         
        
        
            Conditions: Cervical Carcinoma, Human Papillomavirus Infection
        
            
        
    
                
                                    The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
                                
            
            
        Recruiting
                            
            
                The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 Deficiency.             
        
        
    Gender:
                ALL
            Ages:
                1 year and below
            Trial Updated:
                02/06/2025
            
            Locations: Nationwide Children's Hospital, Columbus, Ohio         
        
        
            Conditions: Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy, ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum
        
            
        
    
                
                                    Pediatric Oncology Recovery Trial After Surgery
                                
            
            
        Recruiting
                            
            
                Pediatric Oncologic Recovery Trial After Surgery (PORTS) trial is an investigator-initiated, multicenter, multidisciplinary prospective case-control study of the implementation of an Enhanced Recovery After Surgery (ERAS) protocol at five tertiary-care pediatric hospitals in pediatric patients undergoing abdominal or retroperitoneal surgical resections for cancer. A pilot phase will determine characteristics of a successful protocol implementation and an exploratory phase plans to examine adhere...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 1 month and 18 years
            Trial Updated:
                02/06/2025
            
            Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio         
        
        
            Conditions: Pelvic Cancer
        
            
        
    
                
                                    Smoking Cessation Intervention Development for Homeless Youth
                                
            
            
        Recruiting
                            
            
                This trial develops a contextually tailored and optimized smoking cessation intervention and studies smoking motivations and motivations to quit smoking in homeless youth. Identifying motivations for smoking and motivations to quit smoking may help researchers build a program to help homeless young people quit smoking cigarettes if desired.             
        
        
    Gender:
                ALL
            Ages:
                Between 14 years and 24 years
            Trial Updated:
                02/05/2025
            
            Locations: Ohio State University Comprehensive Cancer Center, Columbus, Ohio         
        
        
            Conditions: Cigarette Smoking-Related Carcinoma
        
            
        
    
                
                                    Transforming Care for Individuals with Childhood-onset Systemic Lupus Erythematosus
                                
            
            
        Recruiting
                            
            
                This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.             
        
        
    Gender:
                ALL
            Ages:
                Between 12 years and 22 years
            Trial Updated:
                02/05/2025
            
            Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio         
        
        
            Conditions: Systemic Lupus Erythematosus of Childhood (Disorder)
        
            
        
    
                
                                    Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults with PKP2 Mutation-associated ARVC
                                
            
            
        Recruiting
                            
            
                This first-in-human study is designed to evaluate the safety, and preliminary efficacy (PD) of TN-401 gene therapy in adult patients with symptomatic PKP2 mutation-associated ARVC.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                02/05/2025
            
            Locations: Cleveland Clinic, Cleveland, Ohio         
        
        
            Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy
        
            
        
    
                
                                    PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
                                
            
            
        Recruiting
                            
            
                This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).
The study contains of 5 arms:
NYHA II Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class II HF patients, where patients have daily access to PAP data.
* Treatment Arm (Group 1)
* Active Control Arm (Group 2)
* Crossover Arm...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/05/2025
            
            Locations: The Christ Hospital- Cincinnati, Cincinnati, Ohio         
        
        
            Conditions: Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure
        
            
        
    
                
                                    Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drainage with respect to a composite post-operative complications of Grade B or C Postoperative pancreatic fistula (POPF), readmission, or organ space surgical site infection following a distal pancreatec...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/05/2025
            
            Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio         
        
        
            Conditions: Cyst of Pancreas, Pancreatectomy, Pancreas Neoplasm
        
            
        
    
                
                                    MyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
                                
            
            
        Recruiting
                            
            
                Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.             
        
        
    Gender:
                ALL
            Ages:
                30 years and above
            Trial Updated:
                02/05/2025
            
            Locations: Cincinnati VA Medical Center, Cincinnati, Ohio         
        
        
            Conditions: COPD
        
            
        
    
                
                                    Impact of Dietary Inflammatory Potential on Breast Cancer Risk
                                
            
            
        Recruiting
                            
            
                This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/05/2025
            
            Locations: Ohio State University Comprehensive Cancer Center, Columbus, Ohio         
        
        
            Conditions: Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Carcinoma, Breast Lobular Carcinoma In Situ, Breast Sclerosing Adenosis
        
            
        
    